Biden’s Vaccine Rule Is Here and Half of Employers Aren’t Ready
(Bloomberg) -- The clock is now ticking for many private employers to set up Covid-19 vaccination and testing programs, but companies aren't anywhere close to being prepared.
The Occupational Safety and Health Administration released guidelines Thursday that follow through on the plan President Joe Biden announced two months ago to use employer mandates to drive up vaccination totals. While the rules should come as no surprise, only half of companies have relayed the implications of the federal policy to employees, a new survey from Gartner Inc. found, and more than half are unsure of how they plan to manage weekly employee testing. One in five companies simply haven't done anything yet.
Business leaders expect 6.4% of employees, on average, to leave due to vaccine requirements, and nearly three-quarters expect some sort of resistance from workers in regard to the federal rules. Since Gartner last surveyed employers in September, opinions have hardened somewhat in favor of firing or punishing workers who refuse the vaccine.
OSHA's emergency temporary standard mandates that workers at U.S. companies with 100 or more employees be fully vaccinated by Jan. 4 or submit to testing, and it follows earlier mandates for health-care workers and federal contractors. Attorneys general from several Republican states have vowed to sue in an effort to block the initiative.
Read more: What's in the Biden Administration's Covid Shot-or-Test Rule
The emergency standard, which OSHA justified by citing the “grave danger” posed by the lingering Coronavirus pandemic, requires covered employers to develop, implement and enforce a mandatory Covid-19 vaccination policy or require employees to undergo regular testing and wear a face covering at work.
How those tests will be implemented, paid for and submitted to federal authorities is still being hashed out, the Gartner survey found, despite companies knowing for two months that some testing regiment would be required. More than half of companies told Gartner they're still working on how to manage the process, while one-quarter said they wouldn't provide or facilitate tests for employees. A smaller percentage said they would provide rapid or PCR tests either on site, or by mail.
No matter how the testing works, vaccine-hesitant employees won't like it, according to Rachel Conn, an employment lawyer and partner at law firm Nixon Peabody LLP.
“I have clients who have employees who are unhappy about testing, period -- regardless of whether they have to pay for it,” Conn said. “Testing is expensive, especially if you're making minimum wage and have to buy a test every week.”
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.